Fidelity Emerging Markets Limited (LON:FEML) lead portfolio manager, Nick Price, shares his latest investment views in response to the impact of Russia’s war with Ukraine. In this wide ranging interview, he..
Real Estate Credit Investments Ltd (LON:RECI) announced its Investment Manager’s monthly Fact Sheet as at 31 March 2022. The highlights of the monthly update are provided below: NAV as at 31 March..
The key message from the 2021 results is that Arbuthnot Banking Group plc (LON:ARBB) is back to profitable growth with an interest-rate-upside kicker. End-2021 assets were at the levels management..
Structured products income fund, Volta Finance Limited (LON:VTA) has published its results for the six month period ended 31 January 2022, attached to this article, and will be available on..
BlackRock Greater Europe Investment Trust plc (LON:BRGE) has two co-managers: Stefan Gries, since June 2017, covering developed European markets, and Sam Vecht, since the fund’s launch in September 2004, covering..
Vector Capital Plc (LON:VCAP), the commercial lending group that offers secured loans primarily to businesses located in the United Kingdom, will be announcing its audited results for the year ended..
Echo Energy plc (LON:ECHO) CEO Martin Hull joins DirectorsTalk Interviews to discuss operational update regarding its Santa Cruz Sur assets, onshore Argentina for Q1 2022. Martin talks us through the..
Kenmare Resources plc (LON:KMR, ISE:KMR) today announced the publication of its Sustainability Report and its inaugural Climate Strategy Report for the year ended 31 December 2021 and advises that both..
Vertu Motors plc (LON: VTU) has announced that on 07 April 2022, it purchased 201,999 ordinary shares of 10p each in the Company on the London Stock Exchange, pursuant to..
DG Innovate plc (LON:DGI), has today announced its admission to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. The..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced the signing of two new ImmunoINSIGHTS commercial contracts. The first contract is with an US-based clinical-stage biopharmaceutical company which..
